CAPRICOR THERAPEUTICS, INC. Earnings Per Share Diluted

Quick Answer

CAPRICOR THERAPEUTICS, INC. reported Earnings Per Share Diluted of $2.26 (loss) per share for the year ending 2025.

  • CAPRICOR THERAPEUTICS, INC. showed a decrease of -96.5% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from CAPRICOR THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2016 to 2025), CAPRICOR THERAPEUTICS, INC.'s Earnings Per Share Diluted has declined by 123.8%.
  • Historical annual values: Fiscal year 2025: $2.26 (loss) per share | Fiscal year 2024: $1.15 (loss) per share | Fiscal year 2023: $0.83 (loss) per share | Fiscal year 2022: $1.18 (loss) per share | Fiscal year 2021: $0.87 (loss) per share | Fiscal year 2020: $0.88 (loss) per share | Fiscal year 2018: $0.52 (loss) per share | Fiscal year 2017: $0.09 per share | Fiscal year 2016: $1.01 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: